Treace Medical Concepts, Inc. Acquisitions, Net of Cash Acquired
Treace Medical Concepts, Inc. (TMCI) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-02-27
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for fiscal 2025 was $0.00.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $20.00M.
- Treace Medical Concepts, Inc. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $20.00M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $20.00M 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $20.00M 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |